Page 102 - Clinical Development News Today

Jason Dong, co-CEO-founder of Mural Health, wants to make sure patients taking part in trials are not out of pocket. He joined OSP while at DIA Global to discuss how his business came about and why it is so important.

/PRNewswire/ -- Bridge Biotherapeutics (KQ288330), a South Korean clinical-stage biotech company developing novel drugs for fibrosis, cancer and inflammation,...

Updated guidelines for risk-based quality management (RBQM) are much more than just for monitoring purposes and can show quality by design concepts, save immeasurable time on manpower and shows there has been a complete mindset shift within the last 15 years, CluePoints says.

LEXINGTON - Curis, Inc., , a biotechnology company focused on the development of emavusertib, an orally available small molecule triple target inhibitor for the treatment of hematologic...

Anorexia nervosa is a notoriously difficult illness to treat. It has the highest mortality rate of any psychiatric disorder, yet there is currently no FDA approved therapy for the condition.

/PRNewswire/ -- Curis, Inc., (Nasdaq: CRIS), a biotechnology company focused on the development of emavusertib, an orally available small molecule triple...

Toenail fungus is an embarrassing problem to have but Scottish health tech firm, Emblation is hopeful its treatment could prove effective.

With the FDA issuing guidance on more diversity within clinical trials, it is a subject many companies are being encouraged to focus on, each with their own approach.

/PRNewswire/ -- The "Alopecia Areata - U.S Market Insight, Epidemiology and Market Forecast - 2032" report has been added to ResearchAndMarkets.coms offering....

/PRNewswire/ -- The "G-Protein Coupled Receptors (GPCRs): Global Strategic Business Report" report has been added to ResearchAndMarkets.coms offering. The...